Innovation1 Biotech
About us
I1Bio recognizes that optimal therapeutic outcomes require addressing complex, interconnected biological pathways. Our proprietary Quantum Core Technology (QCT™) platform analyzes botanical compounds at the atomic level, identifying those with optimal engagement across complementary therapeutic targets. This systems-based approach—inspired by nature’s own strategy—allows us to develop formulations that address complex health challenges through synergistic mechanisms, optimizing efficacy while minimizing side effects.
Scientific Approach
Evidence-Based Methodology
Our scientific approach integrates comprehensive metabolic assessment with personalized nutritional intervention. We employ advanced diagnostic protocols to identify specific physiological imbalances that may benefit from targeted nutritional support. This methodology enables us to address metabolic dysregulation with precision and clinical rigor.
Diagnostic Assessment Protocol
Our clinical team specializes in the application of advanced diagnostic panels that provide detailed analysis of metabolic function, nutritional status, hormone balance, and cellular energetics. These assessments are particularly relevant for patients experiencing post-COVID sequelae and cognitive function concerns. Our comprehensive panels evaluate:
- Metabolic pathway functionality
- Oxidative stress markers
- Mitochondrial function indicators
- Nutritional status assessment
- Hormonal balance evaluation
Clinical Assessment Process
Upon receiving diagnostic results, our team conducts comprehensive biomarker analysis using proprietary assessment algorithms developed under Dr. Arad’s scientific direction. This systematic approach identifies specific patterns of metabolic dysfunction, hormone imbalances, inflammatory activation, mitochondrial impairment, and nutritional deficiencies. Our assessment process correlates objective biomarker findings with clinical presentation, establishing documented evidence of specific nutritional requirements resulting from physiological dysfunction.
Personalized Medical Food Development
Based on comprehensive clinical assessment findings, we develop personalized medical food specifications addressing documented nutritional requirements. These formulations adhere to strict quality control protocols, ensuring each product meets FDA requirements for medical foods under 21 CFR 101.9(j)(8). Our specialized manufacturing capabilities enable precise calibration of bioactive compounds targeted to specific metabolic pathways identified through our diagnostic assessments.
Research Team
Dr. Pesach Arad is a recognized leader in integrative medicine with a focus on metabolic health. With over 25 years in the life sciences, he specializes in comprehensive metabolic assessments, innovative clinical trials, and the prescription of targeted medical food therapies to optimize patient outcomes. His holistic, evidence-based approach integrates advanced diagnostic tools with individualized care strategies, positioning him at the forefront of integrative metabolic medicine.
Dr. Pesach Arad, M.D.
Medical Director
Dr. Dorit Arad brings extensive expertise in nutritional biochemistry and metabolic pathway analysis to Innovation 1 Biotech. Her research background has been instrumental in developing our proprietary assessment algorithms and formulation specifications. Dr. Arad’s scientific direction ensures that our approach remains grounded in current research while pioneering new applications in metabolic health optimization.
Dr. Dorit Arad, Ph.D.
Chief Scientific Officer
Clinical Team
Our qualified healthcare team includes specialists in metabolic medicine, nutritional biochemistry, and integrative health. This multidisciplinary approach allows us to address complex metabolic dysregulation through comprehensive assessment and targeted intervention strategies.
Contact Information
In-Person Consultations
Israel Office
- 23 Rothschild Boulevard Tel Aviv, Israel
- +972 3 555 7890
- israel.office@innovation1bio.com
New York City Office
(Opening Soon) Our new clinical facility in New York City will expand our in-person service capabilities, complementing our current consultation model.
Remote Consultations
HIPAA-Compliant Telehealth
Our telehealth consultations are conducted through VSee, a secure platform that ensures complete protection of patient information with 256-bit AES encryption and meets all HIPAA requirements, including the Business Associate Agreement (BAA).
Structured Telephone Consultations
For patients who prefer telephone interaction, we offer comprehensive HIPAA-compliant telephone consultations with our qualified healthcare professionals.
Schedule a Consultation
To arrange an initial consultation or follow-up appointment, please contact our patient services team: